Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-04-22 | New | $4,141,184 | $4,141,184 | Equity Only | 06b | SEC link |
| 2024-07-31 | Amended | $2,026,000 | $1,201,000 | Debt Only | 06b | SEC link |
| 2024-07-10 | New | $825,000 | $825,000 | Debt Only | 06b | SEC link |
| 2014-08-15 | New | $550,814 | $550,814 | Equity Only | 06b | SEC link |
| 2009-05-12 | New | $40,000 | Unknown | Debt Only | SEC link |
| Name | Role |
|---|---|
| Nicole Bell | Director, Executive |
| Edward Breitschwerdt | Director |
| B. Jefferson Clark | Director, Executive |
| Amanda Elam | Director, Executive |
| Christopher Kelly | Director, Executive |
| Joel Kimbrough | Director |
| Ricardo Maggi | Director |
| Richard West | Director |